AcelRx Pharmaceuticals
ACRX
$0.86
Share price
7.50%
Change (1 day)
40.98%
Change (1 year)
Categories
P/S ratio for AcelRx Pharmaceuticals (ACRX)
P/S ratio as of April 2024 (TTM): 22.4
According to AcelRx Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 22.3947. At the end of 2023 the company had a P/S ratio of 19.1.
P/S ratio history for AcelRx Pharmaceuticals from 2011 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 19.1 | -71.35% |
| 2022 | 66.8 | 181.65% |
| 2021 | 23.7 | 14.51% |
| 2020 | 20.7 | -71.76% |
| 2019 | 73.4 | -13.28% |
| 2018 | 84.6 | 563.38% |
| 2017 | 12.7 | 87.75% |
| 2016 | 6.79 | -24.95% |
| 2015 | 9.05 | -83.95% |
| 2014 | 56.4 | 241.67% |
| 2013 | 16.5 | -74.97% |
| 2012 | 65.9 | 88.28% |
| 2011 | 35.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Recro Pharma
REPH | N/A | N/A | 🇺🇸 USA |
 Cara Therapeutics
CARA | 1.75 | -92.18% | 🇺🇸 USA |